Institute of Agro-Biology

South Korean stocks lost ground with the main index entering a bear market on Thursday as foreign investors intensified their selling after the US F...

The initial public offering of South Korea's LG Energy Solution Ltd. drew a record 11,500 trillion won ($9.65 trillion) in bids from institutional i...

South Korea's benchmark stock index Kospi declined to its lowest closing level in one and a half months on Monday, moving in the opposite direction ...

South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...

Just a couple of years ago, the prevalent market view on the cybersecurity industry was that it would go downhill rather than prosper as public orga...

Mortgage loan growth at banks in South Korea slowed to near a four-year low in November, on the back of tightened lending rules and an interest rate...

Some major South Korean institutional investors have committed to Switzerland-headquartered global asset manager Partners Group's Secondary 2020 Fun...

The National Pension Service added New York-based private equity firm Warburg Pincus LLC to its pool of 58 global real estate investment manager...

Samsung Biologics Co., a global contract development and manufacturing organization (CDMO), has stepped up its partnerships with global big pharmas ...

South Korean private equity firm STIC Investments Inc. has invested $20 million in Vietnam’s e-commerce giant Tiki Corporation’s serie...

Foreign-invested enterprises (FIEs) to be set up in Seoul, South Korea from 2022 will receive increased incentives and reduction in office rent, acc...

South Korean asset manager KTB Asset Management Co. plans to launch two overseas real estate investment trusts (REITs) to invest in Vietnam-based lo...

The National Pension Service (NPS) will increase strategic investments with leading global institutional investors to boost overseas alternative inv...

Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...

Kakao Group’s payment services unit Kakao Pay Corp. set the initial public offering price at the top end of the proposed band thanks to strong...

South Korean Simone Acc. Collection Ltd. has withdrawn its initial public offering plan on lukewarm demand from institutional investors, investment ...

South Korea's STIC Alternative Co. has raised $25 million to invest in a special purpose company of the Carlyle Group, which owns 50% of an oil expo...

South Korea’s Samsung Biologics Co. is gearing up for the drug substance (DS) sector of the messenger ribonucleic acid (mRNA)-based COVID-19 v...

The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...

South Korean game developer Krafton Inc. set the initial public offering (IPO) price at the top end of the proposed band even as the largest domesti...

South Korean game developer Krafton Inc.’s initial public offering, the largest domestic IPO in the second half, drew weaker demand from insti...

Domestic office buildings and logistics centers dominated South Korean institutions' property transactions in the first half of this year, with fier...

South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...

The IPO of SD Biosensor Inc., which has sold the most COVID-19 test kits in the world -- selling more than 700 million kits from February 2020 to Ma...

Hanwha Corp. will develop the bipropellant thruster, a key component for adjusting the satellite’s position in orbit, together with Korea Aero...

South Korean institutional investors, including the Public Officials Benefit Association (POBA) and Yellow Umbrella Mutual Aid Fund, emerged as the ...

Hyundai Motor became the key beneficiary of South Korean institutional investors' heavy buying on the local bourse this month as the global chip sho...

Samsung Biologics will be entering the drug substance segment of the COVID-19 vaccine contract manufacturing business. According to industry sources...

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

South Korea’s Samsung Biologics Co. is in talks with Pfizer Inc.to produce the US drugmaker’s COVID-19 vaccine under a contract manufact...